Karen-Ng Lee Peng, Ahmad Usama Sharif, Gomes Luis, Hunter Keith David, Wan Hong, Hagi-Pavli Eleni, Parkinson Eric Kenneth
Center for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, UK.
Oral Cancer Research & Coordinating Center (OCRCC), Faculty of Dentistry, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Cancers (Basel). 2022 May 26;14(11):2636. doi: 10.3390/cancers14112636.
Potentially pre-malignant oral lesions (PPOLs) are composed of keratinocytes that are either mortal (MPPOL) or immortal (IPPOL) in vitro. We report here that MPPOL, but not generally IPPOL, keratinocytes upregulate various extracellular tumor-promoting cytokines (interleukins 6 and 8) and prostaglandins E1 (ePGE1) and E2 (ePGE2) relative to normal oral keratinocytes (NOKs). ePGE upregulation in MPPOL was independent of PGE receptor status and was associated with some but not all markers of cellular senescence. Nevertheless, ePGE upregulation was dependent on the senescence program, cyclo-oxygenase 2 (COX2) and p38 mitogen-activated protein kinase and was partially regulated by hydrocortisone. Following senescence in the absence of p16, ePGEs accumulated in parallel with a subset of tumor promoting cytokine and metalloproteinase (MMP) transcripts, all of which were ablated by ectopic telomerase. Surprisingly, ataxia telangiectasia mutated (ATM) function was not required for ePGE upregulation and was increased in expression in IPPOL keratinocytes in line with its recently reported role in telomerase function. Only ePGE1 was dependent on p53 function, suggesting that ePGEs 1 and 2 are regulated differently in oral keratinocytes. We show here that ePGE2 stimulates IPPOL keratinocyte proliferation in vitro. Therefore, we propose that MPPOL keratinocytes promote the progression of IPPOL to oral SCC in a pre-cancerous field by supplying PGEs, interleukins and MMPs in a paracrine manner. Our results suggest that the therapeutic targeting of COX-2 might be enhanced by strategies that target keratinocyte senescence.
潜在的癌前口腔病变(PPOLs)由体外具有有限增殖能力(MPPOL)或无限增殖能力(IPPOL)的角质形成细胞组成。我们在此报告,与正常口腔角质形成细胞(NOKs)相比,MPPOL角质形成细胞(而非一般的IPPOL角质形成细胞)会上调多种细胞外促肿瘤细胞因子(白细胞介素6和8)以及前列腺素E1(ePGE1)和E2(ePGE2)。MPPOL中ePGE的上调与PGE受体状态无关,且与细胞衰老的部分而非全部标志物相关。然而,ePGE的上调依赖于衰老程序、环氧化酶2(COX2)和p38丝裂原活化蛋白激酶,并且部分受氢化可的松调节。在缺乏p16的情况下衰老后,ePGEs与一部分促肿瘤细胞因子和金属蛋白酶(MMP)转录本平行积累,所有这些在异位端粒酶作用下均被消除。令人惊讶的是,ePGE上调不需要共济失调毛细血管扩张突变(ATM)功能,并且其在IPPOL角质形成细胞中的表达增加,这与其最近报道的在端粒酶功能中的作用一致。只有ePGE1依赖于p53功能,这表明ePGE1和2在口腔角质形成细胞中的调节方式不同。我们在此表明,ePGE2在体外刺激IPPOL角质形成细胞增殖。因此,我们提出MPPOL角质形成细胞通过旁分泌方式提供PGEs、白细胞介素和MMPs,从而促进IPPOL在癌前区域进展为口腔鳞状细胞癌(SCC)。我们的结果表明,靶向角质形成细胞衰老的策略可能会增强针对COX - 2的治疗效果。